title: Acute rejection accelerates graft coronary disease in transplanted rabbit hearts.
abstract: BACKGROUND
  The relation between episodes of acute rejection and the development of graft coronary arteriosclerosis remains controversial. We examined the hypothesis that acute rejection episodes accelerate graft coronary arteriosclerosis lesion formation in rabbit allografts.
  
  
  RESULTS
  A control group (n = 5) received cyclosporine 5 mg.kg-1.d-1 for 6 weeks after heterotopic heart transplantation. In a rejection group (n = 5), cyclosporine was omitted for 4 days at 1 and 4 weeks after transplantation. We studied cross sections of grafted hearts at 6 weeks and evaluated myocardial rejection grade, incidence, and severity and cell composition of intimal lesions in multiple coronary artery profiles. Episodic withdrawal of cyclosporine augmented myocardial rejection (International Society for Heart and Lung Transplantation grades 0, 0, 0, 0, and 1A in the control group to grades 1A, 1B, 2, 3A, and 3B in the rejection group). Episodes of acute rejection significantly increased the incidence (7.8 +/- 2.7% to 49.7 +/- 1.9%) and severity (from grade 0.10 +/- 0.04 to 0.79 +/- 0.24) of intimal thickening in graft coronary arteries. Most intimal lesions consisted of smooth muscle cells and contained various degrees of T-lymphocyte infiltration but sparse macrophages.
  
  
  CONCLUSIONS
  In this experimental model, episodes of acute rejection precipitated by cyclosporine withdrawal accelerated the development of graft vascular lesion formation. Activation of vascular cells and leukocyte recruitment during acute rejection may thus contribute to the pathogenesis of graft arteriosclerosis.
authors.affiliation: Brigham and Women's Hospital, Boston, Mass, USA.
authors.forename: T
authors.initials: T
authors.lastname: Nakagawa
authors.forename: G K
authors.initials: GK
authors.lastname: Sukhova
authors.forename: E
authors.initials: E
authors.lastname: Rabkin
authors.forename: G L
authors.initials: GL
authors.lastname: Winters
authors.forename: F J
authors.initials: FJ
authors.lastname: Schoen
authors.forename: P
authors.initials: P
authors.lastname: Libby
mesh_terms: D000818:Animals; D001158:Arteries / Q000473:pathology; D003327:Coronary Disease / Q000473:pathology*; D003331:Coronary Vessels / Q000473:pathology; D016572:Cyclosporine / Q000008:administration & dosage; D006084:Graft Rejection / Q000473:pathology; D016027:Heart Transplantation; D011183:Postoperative Complications; D011184:Postoperative Period; D011817:Rabbits; D013997:Time Factors; D014657:Vasculitis / Q000473:pathology; D014680:Veins / Q000473:pathology
chemical_list: D016572:Cyclosporine